[Ip-health] Kassy Perry, speaking on behalf of ?, opposing AB 463, on transparency of drug R&D costs and subsidies

Claire Cassedy claire.cassedy at keionline.org
Wed Apr 29 11:59:31 PDT 2015

During yesterday's debate by the California Assembly Health Committee on
bill AB 463, the Pharmaceutical Transparency Act of 2015, Kassy Perry was
using Twitter to attack the bill, posting links to and repeating
pharmaceutical industry talking points.

Who is Kassy Perry? To learn about this industry PR consultant and her
viewpoint that pharmaceutical cost transparency is "anti-american," read
our write-up on the issue here: http://keionline.org/node/2215

More information about the Ip-health mailing list